Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback